Last reviewed · How we verify

NCT06336460

PENG vs. FIC Blocks in Hip Fractures in the ED

Status unknown NA Last updated 28 March 2024
What this trial tests

NA trial testing Pericapsular Nerve Group (PENG) Block in Hip Fractures in 60 participants. Status unknown.

Timeline
1 April 2024
Primary endpoint
1 April 2026
1 April 2026

Quick facts

Lead sponsorOrange Park Medical Center
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment60
Start date1 April 2024
Primary completion1 April 2026
Estimated completion1 April 2026

Drugs / interventions tested

Conditions studied

Sponsor

Orange Park Medical Center

Who can join

18 and older, any sex, with Hip Fractures or Nerve Block. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is a prospective, randomized clinical trial assessing the efficacy of physician-performed ultrasound-guided pericapsular nerve group (PENG) block vs fascia iliaca compartment (FIC) block for pain control in acute hip fracture.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Pericapsular Nerve Group (PENG) Block

Trials testing the same drug.

Other recruiting trials for Hip Fractures

Currently open trials in the same condition.

Other Orange Park Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06336460.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing